Arachidonic Acid Box and Vials 020620 Clear.png

ARACHIDONIC ACID   Sodium Arachidonate

Catalog No.  101297

Arachidonic Acid (Sodium Arachidonate) is for use in routine platelet aggregation studies for the differential diagnosis of aspirin-like release defects and Storage Pool Disease.

  • Assess the Effect of Aspirin on Platelet Aggregation

  • Detect the Presence of Aspirin-like Release Defects

  • Evaluate the Inhibition of TX A2 Production

  • Confirm Patient Compliance when Aspirin Monotherapy or Dual Antiplatelet Therapy (DAPT) are Prescribed

  • Shelf Life of Two Years

PRODUCT DETAILS

Arachidonic Acid is a fatty acid present in the granules and membranes of human platelets.

It is liberated from phospholipids and, in the presence of the enzyme cyclo-oxygenase, incorporates oxygen to form the endoperoxide prostaglandin G2 (PGG2).  PGG2 is then quickly transformed to prostaglandin H2 (PGH2) which in turn is converted to thromboxane A2 a potent inducer of platelet aggregation. Ingestion of aspirin or aspirin-containing compounds inhibits cyclo-oxygenase mediated oxygen consumption, thus precluding all subsequent events leading to platelet aggregation.

Net Contents:   3 x 0.5 mL

English_Flag.png
Spanish_Flag.png
French_Flag.png
German_Flag.png
Italy_Flag.png

YOU MAY ALSO BE INTERESTED IN:

ADP

ADP%20Box%20and%20Vials%20020620%20Clear_edited.png

AggRecetin®

15mg

AggRecetin%20Box%20and%20Vials%20020620%

AggRecetin®

100mg

AggRecetin%20Bulk%20Box%20and%20Vials%20020620%20Clear_edited.png

Collagen

 

Collagen%20Box%20and%20Vials%20020620%20Clear_edited.png

Epinephrine

Epinephrine%20Box%20%26%20Vial%20020920%20Clear_edited.png